Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults

NCT05685186 is registered in ClinicalTrials.gov with ReCode Therapeutics as lead sponsor.

NCT NCT05685186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05685186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults
Lead sponsor
ReCode Therapeutics
Phase
Observational
Overall status
Completed
Start date
March 8, 2023
Completion date
June 30, 2025
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary ciliary dyskinesia